Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company - Completes sale of Coris Bioconcept SRL to 3B BlackBio Dx Ltd on Friday. Says all closing conditions for the takeover have been satisfied. Company previously announced the sale in late July, with Bhopal, India-based 3B BlackBio to pay £2.2 million up front. Deal includes an additional earn-out worth up to £615,000 based on future performance. Coris Bioconcept specialises in developing, manufacturing and marketing rapid diagnostic tests.
Current stock price: 60.80 pence
12-month change: down 16%
Copyright 2025 Alliance News Ltd. All Rights Reserved.